- Report
- May 2025
- 190 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- February 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- June 2025
- 378 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- May 2025
- 185 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- August 2022
- 117 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- August 2023
- 145 Pages
Global
From €2821EUR$3,150USD£2,405GBP
- Report
- September 2023
- 143 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Report
- February 2023
- 222 Pages
Global
From €3224EUR$3,600USD£2,749GBP
- Report
- February 2023
- 89 Pages
Middle East, Africa
From €1344EUR$1,500USD£1,145GBP
- Report
- February 2023
- 91 Pages
Asia Pacific
From €1344EUR$1,500USD£1,145GBP
- Report
- February 2023
- 89 Pages
Europe
From €1344EUR$1,500USD£1,145GBP
- Report
- February 2023
- 80 Pages
North America
From €1344EUR$1,500USD£1,145GBP
The Joint Pain Injections market is a subset of the Analgesics market, which is focused on providing relief from pain. Joint Pain Injections are used to treat pain caused by arthritis, bursitis, and other joint-related conditions. These injections are typically administered directly into the affected joint, and can provide relief from pain for several weeks or months. The Joint Pain Injections market is composed of a variety of products, including corticosteroids, hyaluronic acid, and platelet-rich plasma. These products are used to reduce inflammation, lubricate the joint, and promote healing.
Some of the companies in the Joint Pain Injections market include Pfizer, Sanofi, and Novartis. Other companies include AbbVie, Merck, and Johnson & Johnson. Show Less Read more
